NCT04804722View on ClinicalTrials.gov

Risk of Developing Dementia and Associated Factors in Patients With Normal Brain FDG PET

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 20, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions
Neurodegenerative DiseasesCognitive Disorder
Interventions
DEVICE

18F-FDG PET-CT (fluorodesoxyglucose positron emission tomography)

18F-FDG PET-CT exams during 30 minutes with injection of radiopharmaceutical product

Trial Locations (1)

54511

Nuclear medicine Department CHRU de NANCY, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER